Liesbeth WeynantsManaging Partner at Hoyng Rokh Monegier LLP
Liesbeth’s practice combines patent litigation and regulatory work with a focus on the life sciences sector. Her work includes regulatory affairs (MA procedures, pricing-reimbursement, clinical trials, compliance and advertising issues, pharmaco- and materiovigilance, supply chain management etc.), as well as advice and litigation on unfair competition, privacy and data protection laws. She also drafts agreements in all of the above fields. Liesbeth often gives compliance trainings as well as lectures on the above matters and is in frequent contact with the authorities and industry bodies.
Liesbeth has extensive experience in late life-cycle management through regulatory and patent-based actions against early generic entry. She provides pre-litigation advice and helps to develop patent portfolio strategies.
Liesbeth’s clients in the life sciences sector include large research-oriented pharmaceutical, medical device and biotech companies, industry bodies and universities, foreign (UK, German, French, US essentially) law firms with advice on local law. Clients for which Liesbeth regularly provides regulatory advice include Allergan, Biogen, Boehringer Ingelheim, Celgene, Daiichi Sankyo, Gedeon Richter, Gilead, J&J, Lundbeck, Menarini, Merck, Novartis, Sanofi, Takeda, Teva (innovative branch) and many others.
Liesbeth also assists industrial clients such as in the automotive industry Porsche EEC racing cars and Votquenne.
In addition to her extensive practical experience, Liesbeth also teaches the IP course in the IFB Biotechnology Masterclass, the VUB biotech Masterclass and has published a number of articles on selected topics in her fields.